US Stock MarketDetailed Quotes
BPMC Blueprint Medicines
- 90.180
- +1.490+1.68%
Close Nov 18 16:00 ET
- 90.180
- 0.0000.00%
Post 20:01 ET
5.73BMarket Cap-43148P/E (TTM)
90.660High88.050Low628.45KVolume88.430Open88.690Pre Close56.36MTurnover1.00%Turnover RatioLossP/E (Static)63.53MShares121.90052wk High18.30P/B5.67BFloat Cap67.00052wk Low--Dividend TTM62.83MShs Float125.610Historical High--Div YieldTTM2.94%Amplitude13.040Historical Low89.676Avg Price1Lot Size
About Blueprint Medicines Company
Blueprint Medicines Corp. is a precision therapy company, which engages in the invention of medicines for people with cancer and blood disorders. The company was founded by Chris Varma, Nicholas B. Lydon, Brian Druker, and Alexis Borisy on October 14, 2008 and is headquartered in Cambridge, MA.
Company Profile
SymbolBPMC
Company NameBlueprint Medicines
Listing DateApr 30, 2015
Issue Price18.00
Founded2008
CEOMs. Kathryn Haviland
MarketNASDAQ
Employees655
Fiscal Year Ends12-31
Address45 Sidney Street
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02139
Phone1-617-374-7580
Company Executives
- Name
- Position
- Salary
- Kathryn Haviland
- Director, President and Chief Executive Officer
- 6.43M
- Dr. Philina Lee, PhD
- Chief Commercial Officer
- --
- Debra Durso-Bumpus
- Chief People Officer
- --
- Michael Landsittel, M.B.A.
- Chief Financial Officer
- 2.19M
- Dr. Becker Hewes, M.D.
- Chief Medical Officer
- --
- Dr. Christopher K. Murray, PhD
- Chief Technical Operations and Quality Officer
- --
- Tracey L. McCain, Esq.
- Chief Legal and Compliance Officer
- --
- Christina Rossi, M.B.A.
- Chief Operating Officer
- 2.81M
- Dr. Percy H. Carter, M.B.A.,PhD
- Chief Scientific Officer
- 2.30M
- Ariel Hurley
- Senior Vice President, Finance and Principal Accounting Officer
- --
- Jeffrey W. Albers, J.D.
- Chairman of the Board
- 526.08K
- Dr. Fouad Namouni, M.D.
- President, Research and Development
- 2.80M
- Alexis A. Borisy, A.M.
- Director
- 397.33K
- Daniella Beckman
- Independent Director
- 422.33K
- Lonnel Coats
- Independent Director
- 419.33K
- Dr. Mark Alan Goldberg, M.D.
- Independent Director
- 419.33K
- Dr. John Tsai, M.D.
- Independent Director
- 769.80K
- Habib Joseph Dable
- Independent Director
- 412.33K
- Dr. Lynn Seely,M.D.
- Lead Independent Director
- 452.33K
- Dr. Nicholas Lydon, F.R.S.,PhD
- Independent Director
- 417.33K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
